Investor Relations

Fusion Antibodies is a CRO that offers a range of antibody engineering services for all stages of therapeutic and diagnostic antibody development.

Latest News

Director/PDMR Shareholding
22 January 2021
Half year Report
20 November 2020
Notice of Results
12 November 2020

View Share Price

Share Price

GBp

updated every 15 minutes

Read more about us

Fusion Antibodies Company Profile

Read More »

View Investor Videos

Investor Videos

Watch latest video »

Sign up for Investor Alerts

Investor Alert

Sign up for Investor Alerts »